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were all cause mortality, MI, stroke and 
repeat revascularization. Odds ratios (OR) 
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calculated. The analysis was performed using 
DerSimonian and Laird random effect model.
Results: In total, six studies (four 
observational and two randomized controlled 
trials) met our inclusion criteria with a total 
of 2198 patients (CABG: 1050, PCI: 1148). 
Patients undergoing CABG had a higher 
incidence of multivessel disease (74.7% vs 
65.7%, p = 0.01) At a mean follow-up of 




compared to PCI group (OR = 0.70, 95% CI = 
0.57 – 0.87; p = 0.001) (Figure 1). The odds 
of MI or repeat revascularization were lower 
with CABG, whereas the odds of stroke were 
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was seen in all-cause mortality.
Conclusion: Our analysis shows that CABG 
is associated with better long-term outcomes 
as compared to PCI in LMCAD patients with 
CKD. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.056
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Background: Transradial access (TRA) 
is now increasingly used for percutaneous 
coronary intervention (PCI) in ST Elevation 
Myocardial Infarction (STEMI) vis-à-vis 
Transfemoral access (TFA). We conducted a 




of the two approaches in STEMI-PCI.
Methods: PubMed, Cochrane, Embase 
databases and major national conference 
proceedings were systematically searched 




outcomes studied were all-cause mortality, 
major adverse cardiovascular events (MACE), 
myocardial infarction (MI) and stroke. Safety 
outcomes included major bleeding and 
vascular complications. Odds ratios (OR) 
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calculated. The analysis was performed using 
DerSimonian and Laird random effects model.
Results: In total, 17 trials met our inclusion 
criteria with a total of 12018 patients 














Figure 1. Forest plots comparing outcomes between CABG and PCI for LMCAD revascularization in CKD patients.
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1). At a mean follow-up of 2.3 +/- 2.8 months, 
rates of all-cause mortality (OR: 0.70, 95% CI 
= 0.56 – 0.88), major bleeding (OR: 0.58, 95% 
CI = 0.44 – 0.76) and vascular complications 
(OR: 0.38, 95% CI = 0.28 – 0.51) were lower 
in TRA as compared to TFA while there was 
no difference in rates of MACE, MI and 
stroke between groups. 
Conclusion: Our analysis shows that TRA is 
associated with better long-term survival as 
compared to TFA along with lower rates of 
major bleeding and vascular complications in 
STEMI patients undergoing PCI. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.057
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Background: A 21 year-old man presented 
with a two-day history of left leg pain and 
swelling following recent admission for non-
traumatic splenic rupture due to presumed 
infectious mononucleosis. He had swelling, 
tenderness and erythema of the left lower 
extremity, primarily surrounding the calf. 
Doppler ultrasound revealed non-occlusive 
deep vein thrombosis (DTV) of the left 
proximal femoral vein and he was started 
on apixaban for anticoagulation. Laboratory 
workup for clotting disorder revealed 
heterozygous Factor V Leiden mutation. 
One week later his leg pain and swelling 
worsened. Repeat Doppler revealed extensive 
progression of the DVT despite appropriate 
Figure 1. Forest plots showing outcomes with transradial and transfemoral approaches in STEMI.
